SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-387152
Filing Date
2014-10-29
Accepted
2014-10-29 16:06:00
Documents
5
Period of Report
2014-10-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d811988d8k.htm 8-K 22610
2 EX-1.1 d811988dex11.htm EX-1.1 207486
3 EX-5.1 d811988dex51.htm EX-5.1 6670
4 EX-99.1 d811988dex991.htm EX-99.1 6300
5 EX-99.2 d811988dex992.htm EX-99.2 6878
  Complete submission text file 0001193125-14-387152.txt   251123
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 141180229
SIC: 2834 Pharmaceutical Preparations